RX
Live / Applied — Second extension granted (statement of use) (as of 20 Oct 2025)
What this means for you
Not registered yet, but its 04 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98343107
- Mark type
- Design + words
- Filed
- 04 Jan 2024
- Published for opposition
- 08 Oct 2024
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Alzheimer's disease, Parkinson's disease, neurological disorders and diseases, neurodegenerative disorders and diseases, autoimmune diseases and age associated disorders and diseases
Owner
- Nuvation Bio Inc., New York, NY, US
- Nuvation Bio Inc., New York, NY, US
Prosecution history
- 21 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Oct 2025 — SOU EXTENSION 2 GRANTED
- 20 Oct 2025 — SOU EXTENSION 2 FILED
- 20 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 10 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 May 2025 — SOU EXTENSION 1 GRANTED
- 09 May 2025 — SOU EXTENSION 1 FILED
- 09 May 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Oct 2024 — PUBLISHED FOR OPPOSITION
- 18 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Sept 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Jul 2024 — ASSIGNED TO EXAMINER
- 22 Apr 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED